Table 1. Demographics of patients at baseline.
| Characteristic | ILD exacerbation post-procedure (n=4) | Patients without ILD exacerbation (n=107) | Total (n=111) |
|---|---|---|---|
| Age (years), median (IQR) | 54.5 (20.8) | 69.0 (15.0) | 69 (17.0) |
| Sex (male), n (%) | 0 | 55 (51.4) | 55 (49.5) |
| Hispanic ethnicity, n (%) | 0 | 1 (0.9) | 1 (0.9) |
| Race, n (%) | |||
| White | 4 (100.0) | 91 (85.0) | 95 (85.6) |
| Black | 0 | 10 (9.3) | 10 (9.0) |
| Hispanic | 0 | 1 (0.9) | 1 (0.9) |
| Asian | 0 | 2 (1.9) | 2 (1.8) |
| BMI (kg/m2), median (IQR) | 33.0 (21.8) | 28.9 (6.5) | 28.9 (7.1) |
| Patients on home oxygen, n (%) | 1 (25.0) | 33 (30.8) | 34 (30.6) |
| Average amount of oxygen (LPM), median (IQR) | 2.0 (4.0) | 2.0 (2.5) | 2.0 (3.0) |
| Prior medical history, n (%) | |||
| Tobacco use (former/current) | 2 (50.0) | 68 (63.6) | 70 (63.1) |
| Marijuana use (former/current) | 1 (25.0) | 11 (10.3) | 12 (10.8) |
| Vaping use (former/current) | 0 | 3 (2.8) | 3 (2.7) |
| Hypertension | 1 (25.0) | 62 (57.9) | 63 (56.8) |
| Type 2 diabetes mellitus | 0 | 28 (26.2) | 28 (25.2) |
| Congestive heart failure | 0 | 13 (12.1) | 13 (11.7) |
| Coronary artery disease | 0 | 25 (23.4) | 25 (22.5) |
| CVA/TIA | 0 | 4 (3.7) | 4 (3.6) |
| Peripheral vascular disease | 0 | 5 (4.7) | 5 (4.5) |
| Chronic hypoxic respiratory failure | 1 (25.0) | 27 (25.2) | 28 (25.2) |
| Chronic obstructive pulmonary disease | 1 (25.0) | 26 (24.3) | 27 (24.3) |
| Asthma | 1 (25.0) | 13 (12.1) | 14 (12.6) |
| Chronic kidney disease | 0 | 9 (8.4) | 9 (8.1) |
| Dementia | 0 | 2 (1.9) | 2 (1.8) |
| Cirrhosis | 0 | 2 (1.9) | 2 (1.8) |
| Immunocompromising condition | 1 (25.0) | 13 (12.1) | 14 (12.6) |
| Common variable immunodeficiency | 0 | 3 (2.8) | 3 (2.7) |
ILD, interstitial lung disease; IQR, interquartile range; BMI, body mass index; LPM, liters per minute; CVA, cerebrovascular accident; TIA, transient ischemic attack.